| [1] |
GERTZ M A.Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management[J]. Am J Hematol,2017,92(2):209-217.
|
| [2] |
KAPOOR P,ANSELL S M,FONSECA R,et al.Diagnosis and management of Waldenström macroglobulinemia: Mayo stratification of macroglobulinemia and risk-adapted therapy (mSMART) guidelines 2016[J]. JAMA Oncol,2017,3(9):1257-1265.
|
| [3] |
PAULUS A,AILAWADHI S,CHANAN-KHAN A.Novel therapeutic targets in Waldenstrom macroglobulinemia[J]. Best Pract Res Clin Haematol,2016, 29(2):216-228.
|
| [4] |
D'ANGELO G,HOTZ A M,MONTI M. Lymphoplasmacytic non-Hodgkin lymphoma/Waldenström's macroglobulinemia with CD5+, CD23+, and CD10[J]. Blood Res,2013, 48(4):300-303.
|
| [5] |
GAVRIATOPOULOU M,TERPOS E,KASTRITIS E,et al.Current treatment options and investigational drugs for Waldenstrom's macroglobulinemia[J]. Expert Opin Investig Drugs,2017, 26(2):197-205.
|
| [6] |
VARETTONI M,ARCAINI L,ZIBELLINI S,et al.Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms[J]. Blood,2013, 121(13):2522-2528.
|
| [7] |
TREON S P,HUNTER Z R.A new era for Waldenstrom macroglobulinemia: MYD88 L265P[J]. Blood,2013, 121(22):4434-4436.
|
| [8] |
JALALI S,ANSELL S M.Bone marrow microenvironment in Waldenstrom's macroglobulinemia[J]. Best Pract Res Clin Haematol,2016, 29(2):148-155.
|
| [9] |
XU L,HUNTER Z R,YANG G,et al.MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction[J]. Blood,2013, 121(11):2051-2058.
|
| [10] |
CASTILLO J J,HUNTER Z R,YANG G,et al.Future therapeutic options for patients with Waldenström macroglobulinemia[J]. Best Pract Res Clin Haematol,2016, 29(2):206-215.
|
| [11] |
余和平. 华氏巨球蛋白血症的治疗进展[J].世界临床药物,2015,36(12):864.
|
| [12] |
LIN A B,SHEYMAN A T,JAMPOL L M.Unusual serous retinal detachment in a patient with waldenstrom macroglobulinemia: a case report[J]. Retin Cases Brief Rep,2017. [Epub ahead of print]
|
| [13] |
BAKER P S,GARG S J,FINEMAN M S,et al.Serous macular detachment in Waldenström macroglobulinemia: a report of four cases[J]. Am J Ophthalmol,2013, 155(3):448-455.
|
| [14] |
路瑾,黄晓军. Waldenstrom巨球蛋白血症的治疗进展[J]. 临床血液学杂志,2011,24(5):562-565.
|
| [15] |
CASTILLO J J,GUSTINE J N,MEID K,et al.Idelalisib in Waldenström macroglobulinemia: high incidence of hepatotoxicity[J]. Leuk Lymphoma,2017, 58(4):1002-1004.
|
| [16] |
肖展翅, 盛瑞林, 王昌锋,等. 以难治性咳嗽为首发表现的Waldenstrom巨球蛋白血症[J]. 临床误诊误治,2015,33(2):34-36.
|
